Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 2016 Apr 1;126(4):1607. doi: 10.1172/JCI87425

Immune activation caused by vascular oxidation promotes fibrosis and hypertension

Jing Wu, Mohamed A Saleh, Annet Kirabo, Hana A Itani, Kim Ramil C Montaniel, Liang Xiao, Wei Chen, Raymond L Mernaugh, Hua Cai, Kenneth E Bernstein, Jörg J Goronzy, Cornelia M Weyand, John A Curci, Natalia R Barbaro, Heitor Moreno, Sean S Davies, L Jackson Roberts II, Meena S Madhur, David G Harrison
PMCID: PMC4811163  PMID: 27035819

Original citation: J Clin Invest. 2016;126(1):50–67. doi:10.1172/JCI80761.

Citation for this corrigendum: J Clin Invest. 2016;126(4):1607. doi:10.1172/JCI87425.

During the assembly of Figure 10B, incorrect flow cytometry panels were inadvertently included for the Tgsm/p22phox + tempol sample. In addition, a different replicate is now provided for the Tgsm/p22phox sample in Figure 10A. The correct figure panels are below.

graphic file with name JCI87425.f10.jpg

Open in a new tab

The authors regret the errors.

Footnotes

See the related article beginning on page 50.

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES